Diamond BioFund Inc. (6901) Stock Statistics & Valuation Metrics
Total Valuation
Diamond BioFund Inc. has a market cap or net worth of TWD 12.25B. The enterprise value is TWD 13.89B.
- Market Cap
- TWD 12.25B
- Enterprise Value
- TWD 13.89B
Share Statistics
Diamond BioFund Inc. has 853,950,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 853,950,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.03%
Financial Efficiency
Diamond BioFund Inc.’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -13.66%.
- Return on Equity (ROE)
- -0.13
- Return on Assets (ROA)
- -0.13
- Return on Invested Capital (ROIC)
- -13.66%
- Return on Capital Employed (ROCE)
- -0.14
- Revenue Per Employee
- -20.55K
- Profits Per Employee
- -40.51M
- Employee Count
- 29
- Asset Turnover
- -0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Diamond BioFund Inc. is 4.17. Diamond BioFund Inc.’s PEG ratio is 0.00.
- PE Ratio
- 4.17
- PS Ratio
- 3.90
- PB Ratio
- 0.99
- Price to FCF
- -158.24
- Price to Operating Cash Flow
- -158.41
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Diamond BioFund Inc. had revenue of -596.00K and earned -1.17B in profits. Earnings per share was -1.38.
- Revenue
- -596.00K
- Gross Profit
- -28.58M
- Operating Income
- -1.28B
- Pretax Income
- -1.17B
- Net Income
- -1.17B
- EBITDA
- -1.14B
- Earnings Per Share (EPS)
- -1.38
Cash Flow
In the last 12 months, operating cash flow was -76.88M and capital expenditures -237,000, giving a free cash flow of -77.12M billion.
- Operating Cash Flow
- -76.88M
- Free Cash Flow
- -77.12M
- Free Cash Flow per Share
- -0.09
Dividends & Yields
Diamond BioFund Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.63%
- Earnings Yield
- 23.92%
Stock Price Statistics
- Beta
- 0.43
- 52-Week Price Change
- -17.77%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 29.18
- Average Volume (3m)
- 1.95M
Important Dates
Diamond BioFund Inc. upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
Diamond BioFund Inc. as a current ratio of 112.05, with Debt / Equity ratio of 1.02%
- Current Ratio
- 112.05
- Quick Ratio
- 112.05
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.33
- Interest Coverage Ratio
- -414.04
Taxes
In the past 12 months, Diamond BioFund Inc. has paid 918.00K in taxes.
- Income Tax
- 918.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Diamond BioFund Inc. EV to EBITDA ratio is 3.33, with an EV/FCF ratio of -127.00.
- EV to Sales
- 3.13
- EV to EBITDA
- 3.33
- EV to Free Cash Flow
- -127.00
- EV to Operating Cash Flow
- -127.39
Balance Sheet
Diamond BioFund Inc. has TWD 2.53B in cash and marketable securities with TWD 81.72M in debt, giving a net cash position of TWD 2.45B billion.
- Cash & Marketable Securities
- TWD 2.53B
- Total Debt
- TWD 81.72M
- Net Cash
- TWD 2.45B
- Net Cash Per Share
- TWD 2.87
- Tangible Book Value Per Share
- TWD 14.45
Margins
Gross margin is 99.14%, with operating margin of 91.62%, and net profit margin of 93.44%.
- Gross Margin
- 99.14%
- Operating Margin
- 91.62%
- Pretax Margin
- 93.44%
- Net Profit Margin
- 93.44%
- EBITDA Margin
- 93.93%
- EBIT Margin
- 93.08%
